CRBU
Price
$1.56
Change
-$0.04 (-2.48%)
Updated
Aug 14, 12:14 PM (EDT)
Capitalization
159.68M
88 days until earnings call
Intraday BUY SELL Signals
CRSP
Price
$52.78
Change
-$1.21 (-2.24%)
Updated
Aug 14, 12:14 PM (EDT)
Capitalization
5.22B
82 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRBU vs CRSP

CRBU vs CRSP Comparison Chart in %
View a ticker or compare two or three
VS
CRBU vs. CRSP commentary
Aug 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBU is a StrongBuy and CRSP is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 14, 2026
Stock price -- (CRBU: $1.61 vs. CRSP: $53.99)
Brand notoriety: CRBU and CRSP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBU: 48% vs. CRSP: 47%
Market capitalization -- CRBU: $159.68M vs. CRSP: $5.22B
CRBU [@Biotechnology] is valued at $159.68M. CRSP’s [@Biotechnology] market capitalization is $5.22B. The market cap for tickers in the [@Biotechnology] industry ranges from $130.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBU’s FA Score shows that 1 FA rating(s) are green whileCRSP’s FA Score has 0 green FA rating(s).

  • CRBU’s FA Score: 1 green, 4 red.
  • CRSP’s FA Score: 0 green, 5 red.
According to our system of comparison, CRBU is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBU’s TA Score shows that 4 TA indicator(s) are bullish while CRSP’s TA Score has 6 bullish TA indicator(s).

  • CRBU’s TA Score: 4 bullish, 4 bearish.
  • CRSP’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, CRSP is a better buy in the short-term than CRBU.

Price Growth

CRBU (@Biotechnology) experienced а -1.83% price change this week, while CRSP (@Biotechnology) price change was +4.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.08%. For the same industry, the average monthly price growth was -1.56%, and the average quarterly price growth was +3040.81%.

Reported Earning Dates

CRBU is expected to report earnings on Nov 10, 2026.

CRSP is expected to report earnings on Nov 04, 2026.

Industries' Descriptions

@Biotechnology (+1.08% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($5.22B) has a higher market cap than CRBU($160M). CRSP YTD gains are higher at: 2.956 vs. CRBU (1.258). CRBU has higher annual earnings (EBITDA): -116.43M vs. CRSP (-627.33M). CRSP has more cash in the bank: 2.44B vs. CRBU (118M). CRBU has less debt than CRSP: CRBU (26.9M) vs CRSP (788M). CRBU has higher revenues than CRSP: CRBU (11.2M) vs CRSP (1M).
CRBUCRSPCRBU / CRSP
Capitalization160M5.22B3%
EBITDA-116.43M-627.33M19%
Gain YTD1.2582.95643%
P/E RatioN/AN/A-
Revenue11.2M1M1,120%
Total Cash118M2.44B5%
Total Debt26.9M788M3%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
23
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
75
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRBUCRSP
RSI
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
83%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 11 days ago
79%
Declines
ODDS (%)
Bearish Trend 17 days ago
88%
Bearish Trend 9 days ago
82%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
CRBU
Daily Signal:
Gain/Loss:
CRSP
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GCOR40.620.13
+0.33%
Goldman Sachs Access US Aggregate Bd ETF
XCNY33.490.06
+0.18%
State Street® SPDR® S&P EM ex-China ETF
CPSM29.530.05
+0.17%
Calamos S&P 500 Str Alt Prt ETF-May
XTWO48.880.06
+0.11%
BondBloxx Bloomberg Two YrTrgDurUSTrsETF
SPEM52.30-0.07
-0.13%
State Street® SPDR® Portfolio EM ETF

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with EDIT. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
-5.29%
EDIT - CRBU
64%
Loosely correlated
-1.06%
SANA - CRBU
54%
Loosely correlated
-2.65%
CRSP - CRBU
54%
Loosely correlated
N/A
RXRX - CRBU
52%
Loosely correlated
+0.61%
AXON - CRBU
50%
Loosely correlated
+2.64%
More

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with BEAM. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
N/A
BEAM - CRSP
75%
Closely correlated
-0.75%
PRME - CRSP
66%
Loosely correlated
-0.94%
RXRX - CRSP
62%
Loosely correlated
+0.61%
NTLA - CRSP
61%
Loosely correlated
-2.15%
EDIT - CRSP
60%
Loosely correlated
-1.06%
More